1st Edition

Handbook of Evidence-Based Pharmacist Care: Clinical, Economic, and Humanistic Impacts Volume 10: Diseases and Disorders of Special Populations

By Yaser Mohammed Al-Worafi Copyright 2026
220 Pages
by Apple Academic Press

220 Pages
by Apple Academic Press

220 Pages
by Apple Academic Press

Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate, patient-centered care, this new series of handbooks aims to fill this gap by showcasing the expanded roles and responsibilities of pharmacists. It will be first of its kind to provide comprehensive information about evidence-based pharmacist care,... Read more

Preface

1. Geriatric Diseases, Conditions, and Disorders

2. Pediatric Diseases, Conditions, and Disorders

3. Adolescent Diseases, Conditions, and Disorders

4. Pregnancy Diseases, Conditions, and Disorders

5. Nursing Homes and Homeless People

6. Immigrants and Refugees' Diseases, Conditions, and Disorders

7. People with Disabilities' Diseases, Conditions, and Disorders

8 Ethnic and Racial Minorities' Diseases, Conditions, and Disorders

9. Rural Population Diseases, Conditions, and Disorders

Index

Biography

Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patient care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.